# Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)

> **NCT00796770** · PHASE1 · COMPLETED · sponsor: **Baylor Research Institute** · enrollment: 19 (actual)

## Conditions studied

- HIV

## Interventions

- **BIOLOGICAL:** Dendritic Cell Vaccine

## Key facts

- **NCT ID:** NCT00796770
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2017-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796770, "Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00796770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*